| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 38 | 2022 | 473 | 9.070 |
Why?
|
| Echocardiography, Transesophageal | 16 | 2018 | 346 | 2.610 |
Why?
|
| Cardiopulmonary Bypass | 15 | 2024 | 158 | 2.510 |
Why?
|
| Minimally Invasive Surgical Procedures | 9 | 2022 | 251 | 2.480 |
Why?
|
| Hemodynamics | 10 | 2022 | 728 | 2.400 |
Why?
|
| Heart-Assist Devices | 11 | 2023 | 752 | 2.190 |
Why?
|
| Coronary Artery Bypass | 13 | 2019 | 235 | 2.170 |
Why?
|
| Coronary Artery Disease | 6 | 2023 | 361 | 2.070 |
Why?
|
| Postoperative Complications | 17 | 2020 | 2285 | 1.950 |
Why?
|
| Pain, Postoperative | 11 | 2015 | 248 | 1.840 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2021 | 179 | 1.770 |
Why?
|
| Monitoring, Intraoperative | 6 | 2018 | 110 | 1.730 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2020 | 78 | 1.730 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 373 | 1.650 |
Why?
|
| Shock, Cardiogenic | 4 | 2023 | 104 | 1.580 |
Why?
|
| Humans | 125 | 2024 | 88611 | 1.550 |
Why?
|
| Myocardial Revascularization | 2 | 2020 | 28 | 1.470 |
Why?
|
| Heart Diseases | 5 | 2021 | 297 | 1.390 |
Why?
|
| Neuromuscular Blockade | 2 | 2019 | 26 | 1.340 |
Why?
|
| Morphine | 5 | 2021 | 130 | 1.290 |
Why?
|
| Analgesia | 4 | 2021 | 57 | 1.230 |
Why?
|
| Anesthesia, Epidural | 6 | 2009 | 32 | 1.200 |
Why?
|
| Aortic Valve | 7 | 2023 | 243 | 1.160 |
Why?
|
| Mitral Valve | 9 | 2021 | 260 | 1.130 |
Why?
|
| Catheterization | 4 | 2015 | 238 | 1.130 |
Why?
|
| Aortic Valve Insufficiency | 4 | 2018 | 131 | 1.110 |
Why?
|
| Heart Valve Diseases | 3 | 2023 | 115 | 1.060 |
Why?
|
| Analgesics, Opioid | 5 | 2021 | 436 | 1.000 |
Why?
|
| Spinal Cord Ischemia | 2 | 2021 | 8 | 0.980 |
Why?
|
| Heart Arrest, Induced | 2 | 2022 | 31 | 0.970 |
Why?
|
| Catheterization, Swan-Ganz | 2 | 2022 | 25 | 0.960 |
Why?
|
| Heart Neoplasms | 2 | 2023 | 63 | 0.910 |
Why?
|
| Intraoperative Complications | 8 | 2019 | 188 | 0.910 |
Why?
|
| Myocardium | 3 | 2024 | 570 | 0.900 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 42 | 0.890 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 185 | 0.890 |
Why?
|
| Pulmonary Artery | 4 | 2022 | 317 | 0.880 |
Why?
|
| Intubation, Intratracheal | 6 | 2001 | 145 | 0.880 |
Why?
|
| Anesthesia, Intravenous | 2 | 2019 | 35 | 0.870 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2023 | 52 | 0.860 |
Why?
|
| Myocardial Contraction | 1 | 2024 | 252 | 0.850 |
Why?
|
| Respiration, Artificial | 3 | 2019 | 350 | 0.810 |
Why?
|
| Anesthesia | 5 | 2015 | 169 | 0.800 |
Why?
|
| Endocarditis | 1 | 2021 | 21 | 0.800 |
Why?
|
| Endocarditis, Bacterial | 1 | 2021 | 34 | 0.790 |
Why?
|
| Review Literature as Topic | 1 | 2021 | 21 | 0.780 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2021 | 20 | 0.780 |
Why?
|
| Pulmonary Edema | 2 | 2021 | 50 | 0.780 |
Why?
|
| Coronary Circulation | 1 | 2022 | 131 | 0.780 |
Why?
|
| Intraoperative Care | 3 | 2018 | 84 | 0.780 |
Why?
|
| Writing | 1 | 2021 | 28 | 0.770 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2021 | 18 | 0.770 |
Why?
|
| Middle Aged | 43 | 2021 | 25699 | 0.770 |
Why?
|
| Thoracic Surgery | 1 | 2021 | 43 | 0.770 |
Why?
|
| Brain Injuries | 1 | 2023 | 163 | 0.760 |
Why?
|
| Robotics | 3 | 2013 | 268 | 0.750 |
Why?
|
| Patient Handoff | 1 | 2022 | 95 | 0.740 |
Why?
|
| Hypotension | 3 | 2019 | 70 | 0.740 |
Why?
|
| Goiter, Substernal | 1 | 2020 | 3 | 0.730 |
Why?
|
| Myxoma | 1 | 2020 | 30 | 0.720 |
Why?
|
| Embolism | 1 | 2020 | 32 | 0.720 |
Why?
|
| Arachnodactyly | 1 | 2020 | 2 | 0.720 |
Why?
|
| Robotic Surgical Procedures | 3 | 2021 | 298 | 0.720 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 14 | 0.710 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 29 | 0.710 |
Why?
|
| Medicine | 1 | 2021 | 90 | 0.700 |
Why?
|
| Thoracic Injuries | 1 | 2020 | 33 | 0.700 |
Why?
|
| Myocardial Ischemia | 2 | 2020 | 161 | 0.700 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2019 | 37 | 0.700 |
Why?
|
| Lung Injury | 1 | 2020 | 53 | 0.690 |
Why?
|
| Kidney Diseases | 1 | 2022 | 319 | 0.690 |
Why?
|
| Hospital Rapid Response Team | 1 | 2019 | 27 | 0.680 |
Why?
|
| Aged | 33 | 2021 | 18932 | 0.680 |
Why?
|
| Male | 51 | 2023 | 42012 | 0.680 |
Why?
|
| Aorta | 4 | 2022 | 286 | 0.670 |
Why?
|
| Craniosynostoses | 1 | 2020 | 77 | 0.670 |
Why?
|
| Marriage | 1 | 2019 | 25 | 0.660 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 19 | 0.660 |
Why?
|
| Heparin | 3 | 2021 | 184 | 0.660 |
Why?
|
| Airway Obstruction | 1 | 2019 | 110 | 0.650 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 29 | 0.640 |
Why?
|
| Analgesia, Epidural | 5 | 2006 | 38 | 0.630 |
Why?
|
| Prospective Studies | 15 | 2018 | 4271 | 0.630 |
Why?
|
| Bronchoscopy | 1 | 2019 | 157 | 0.620 |
Why?
|
| Wireless Technology | 1 | 2018 | 19 | 0.620 |
Why?
|
| Heart Failure | 4 | 2023 | 1171 | 0.620 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 30 | 0.610 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 139 | 0.600 |
Why?
|
| Vena Cava, Inferior | 1 | 2019 | 144 | 0.590 |
Why?
|
| Cystectomy | 1 | 2018 | 105 | 0.590 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2018 | 82 | 0.590 |
Why?
|
| Female | 45 | 2021 | 45759 | 0.590 |
Why?
|
| Delirium | 1 | 2017 | 72 | 0.570 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2016 | 191 | 0.570 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 365 | 0.560 |
Why?
|
| Methylprednisolone | 4 | 2002 | 66 | 0.550 |
Why?
|
| Protamines | 1 | 2015 | 8 | 0.540 |
Why?
|
| Heart Injuries | 1 | 2015 | 17 | 0.530 |
Why?
|
| Lung Transplantation | 5 | 2017 | 278 | 0.530 |
Why?
|
| Cardiac Tamponade | 1 | 2015 | 20 | 0.530 |
Why?
|
| Mitochondria | 1 | 2019 | 552 | 0.520 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 308 | 0.520 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 141 | 0.510 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2015 | 10 | 0.510 |
Why?
|
| Anesthesia, Conduction | 1 | 2015 | 18 | 0.500 |
Why?
|
| Lung | 6 | 2017 | 1243 | 0.490 |
Why?
|
| Anesthetics | 1 | 2015 | 53 | 0.490 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 482 | 0.490 |
Why?
|
| Injections, Spinal | 8 | 2021 | 45 | 0.490 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 6723 | 0.480 |
Why?
|
| Septal Occluder Device | 2 | 2013 | 43 | 0.480 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2015 | 177 | 0.470 |
Why?
|
| Preoperative Care | 2 | 2013 | 398 | 0.470 |
Why?
|
| Angiotensins | 1 | 2013 | 5 | 0.450 |
Why?
|
| Glucocorticoids | 3 | 2002 | 358 | 0.440 |
Why?
|
| Heart Transplantation | 1 | 2019 | 720 | 0.440 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 379 | 0.440 |
Why?
|
| Postoperative Hemorrhage | 2 | 2019 | 46 | 0.430 |
Why?
|
| Aprotinin | 2 | 2009 | 26 | 0.430 |
Why?
|
| Graft Rejection | 1 | 2018 | 1083 | 0.430 |
Why?
|
| Anesthesia, Spinal | 3 | 2005 | 15 | 0.420 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 126 | 0.400 |
Why?
|
| Hypoxia | 3 | 2023 | 650 | 0.390 |
Why?
|
| Midazolam | 2 | 2001 | 48 | 0.370 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2002 | 50 | 0.370 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 98 | 0.370 |
Why?
|
| Ventricular Function | 2 | 2020 | 53 | 0.370 |
Why?
|
| Blood Transfusion | 3 | 2019 | 164 | 0.350 |
Why?
|
| Plasma | 1 | 2009 | 51 | 0.350 |
Why?
|
| Lung Diseases | 3 | 2018 | 269 | 0.340 |
Why?
|
| Adult | 25 | 2018 | 26348 | 0.340 |
Why?
|
| Catheters | 2 | 2022 | 76 | 0.340 |
Why?
|
| Anesthetics, Inhalation | 2 | 2024 | 98 | 0.340 |
Why?
|
| Surgical Sponges | 1 | 2009 | 3 | 0.340 |
Why?
|
| Risk Factors | 5 | 2022 | 5449 | 0.330 |
Why?
|
| Erythrocyte Transfusion | 1 | 2009 | 72 | 0.330 |
Why?
|
| Recovery of Function | 2 | 2020 | 291 | 0.330 |
Why?
|
| Anesthesia, General | 4 | 2005 | 116 | 0.320 |
Why?
|
| Anesthetics, Intravenous | 2 | 1999 | 41 | 0.320 |
Why?
|
| Catheterization, Central Venous | 2 | 2007 | 115 | 0.320 |
Why?
|
| Endoscopy | 1 | 2011 | 344 | 0.310 |
Why?
|
| Equipment Failure | 2 | 2022 | 121 | 0.310 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2001 | 342 | 0.300 |
Why?
|
| Double-Blind Method | 6 | 2021 | 1716 | 0.290 |
Why?
|
| Creatinine | 2 | 2022 | 295 | 0.290 |
Why?
|
| Hypothermia, Induced | 3 | 2015 | 79 | 0.290 |
Why?
|
| Risk Assessment | 5 | 2020 | 2286 | 0.290 |
Why?
|
| Treatment Outcome | 6 | 2020 | 8178 | 0.290 |
Why?
|
| Neck | 1 | 2007 | 102 | 0.270 |
Why?
|
| Anesthesia, Endotracheal | 1 | 2006 | 6 | 0.270 |
Why?
|
| Oxygen | 3 | 2015 | 745 | 0.270 |
Why?
|
| Length of Stay | 4 | 2018 | 726 | 0.270 |
Why?
|
| Carotid Artery Diseases | 2 | 2023 | 98 | 0.270 |
Why?
|
| Heart Atria | 2 | 2020 | 281 | 0.270 |
Why?
|
| Ischemia | 2 | 2021 | 251 | 0.270 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.260 |
Why?
|
| Hematoma | 1 | 2005 | 107 | 0.250 |
Why?
|
| Thromboembolism | 1 | 2005 | 119 | 0.250 |
Why?
|
| Aortic Aneurysm | 2 | 2013 | 80 | 0.240 |
Why?
|
| Operating Rooms | 2 | 2022 | 128 | 0.230 |
Why?
|
| Heart | 2 | 2018 | 572 | 0.230 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 64 | 0.230 |
Why?
|
| Hypercapnia | 1 | 2023 | 44 | 0.230 |
Why?
|
| Anesthesiology | 2 | 2018 | 160 | 0.230 |
Why?
|
| Eisenmenger Complex | 2 | 2013 | 6 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2024 | 84 | 0.220 |
Why?
|
| Fibroma | 1 | 2023 | 33 | 0.220 |
Why?
|
| Echocardiography | 2 | 2013 | 933 | 0.220 |
Why?
|
| Endarterectomy, Carotid | 1 | 2023 | 75 | 0.220 |
Why?
|
| Reoperation | 2 | 2020 | 605 | 0.220 |
Why?
|
| Retrospective Studies | 6 | 2021 | 8893 | 0.210 |
Why?
|
| Analgesics | 1 | 2003 | 119 | 0.210 |
Why?
|
| Paraplegia | 1 | 2001 | 17 | 0.200 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 3655 | 0.200 |
Why?
|
| Anticoagulants | 2 | 2021 | 423 | 0.200 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 348 | 0.200 |
Why?
|
| Heart Ventricles | 2 | 2018 | 779 | 0.200 |
Why?
|
| Perfusion | 2 | 2024 | 230 | 0.200 |
Why?
|
| Surgical Procedures, Operative | 3 | 2010 | 205 | 0.190 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 2001 | 10 | 0.190 |
Why?
|
| Blood Flow Velocity | 1 | 2022 | 199 | 0.190 |
Why?
|
| Inflammation | 2 | 2019 | 961 | 0.190 |
Why?
|
| Contraindications, Procedure | 1 | 2020 | 6 | 0.190 |
Why?
|
| Thoracic Nerves | 1 | 2000 | 2 | 0.190 |
Why?
|
| Pheochromocytoma | 1 | 2021 | 50 | 0.190 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2015 | 516 | 0.180 |
Why?
|
| Syringes | 1 | 2020 | 13 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2001 | 89 | 0.180 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2021 | 82 | 0.180 |
Why?
|
| Diffusion of Innovation | 1 | 2020 | 71 | 0.180 |
Why?
|
| Thrombectomy | 1 | 2021 | 171 | 0.180 |
Why?
|
| Argon Plasma Coagulation | 1 | 2019 | 6 | 0.180 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2019 | 6 | 0.180 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 7 | 0.180 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2018 | 17 | 0.180 |
Why?
|
| Glycation End Products, Advanced | 2 | 2018 | 11 | 0.180 |
Why?
|
| Spinal Cord | 1 | 2021 | 255 | 0.170 |
Why?
|
| History, 21st Century | 1 | 2020 | 177 | 0.170 |
Why?
|
| Respiratory Insufficiency | 2 | 2019 | 159 | 0.170 |
Why?
|
| Biomarkers | 2 | 2019 | 1759 | 0.170 |
Why?
|
| Fentanyl | 1 | 1999 | 67 | 0.170 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 136 | 0.170 |
Why?
|
| Thyroidectomy | 1 | 2020 | 170 | 0.170 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2020 | 307 | 0.170 |
Why?
|
| Succinylcholine | 1 | 2018 | 14 | 0.170 |
Why?
|
| Arm | 1 | 1999 | 97 | 0.170 |
Why?
|
| Hypoglycemia | 1 | 1999 | 107 | 0.160 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 20 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 166 | 0.160 |
Why?
|
| Mortality | 1 | 2019 | 150 | 0.160 |
Why?
|
| Anesthesia, Cardiac Procedures | 1 | 2018 | 1 | 0.160 |
Why?
|
| Ventricular Fibrillation | 2 | 2016 | 66 | 0.160 |
Why?
|
| Sodium Chloride | 1 | 2018 | 87 | 0.160 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 218 | 0.160 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 228 | 0.160 |
Why?
|
| Laser Therapy | 1 | 2019 | 149 | 0.150 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 195 | 0.150 |
Why?
|
| Pneumonectomy | 1 | 2020 | 205 | 0.150 |
Why?
|
| Allografts | 1 | 2018 | 177 | 0.150 |
Why?
|
| Mentoring | 1 | 2018 | 32 | 0.150 |
Why?
|
| Spleen | 1 | 2018 | 431 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2018 | 51 | 0.150 |
Why?
|
| Organ Preservation | 1 | 2017 | 102 | 0.150 |
Why?
|
| Mentors | 1 | 2018 | 82 | 0.140 |
Why?
|
| Pneumonia | 1 | 2018 | 183 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 352 | 0.140 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 21 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2018 | 354 | 0.140 |
Why?
|
| Propofol | 1 | 1997 | 91 | 0.140 |
Why?
|
| Stents | 1 | 2019 | 395 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 195 | 0.140 |
Why?
|
| Intraoperative Period | 3 | 2017 | 90 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2018 | 186 | 0.140 |
Why?
|
| Stroke | 2 | 2019 | 980 | 0.140 |
Why?
|
| Hemoglobinopathies | 1 | 2016 | 10 | 0.140 |
Why?
|
| Time Factors | 5 | 2011 | 5319 | 0.140 |
Why?
|
| Tricuspid Valve | 2 | 2007 | 97 | 0.130 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 96 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 1709 | 0.130 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 577 | 0.130 |
Why?
|
| Coronary Sinus | 1 | 2015 | 8 | 0.130 |
Why?
|
| Acidosis | 1 | 1995 | 55 | 0.130 |
Why?
|
| Brain | 2 | 2023 | 2268 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1167 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 30 | 0.130 |
Why?
|
| Blood Glucose | 1 | 1999 | 840 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2015 | 38 | 0.130 |
Why?
|
| Pregnancy | 2 | 2021 | 2996 | 0.130 |
Why?
|
| Narcotics | 1 | 1995 | 70 | 0.130 |
Why?
|
| Cardiomyopathies | 2 | 2018 | 260 | 0.130 |
Why?
|
| Atrial Appendage | 1 | 2015 | 30 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2746 | 0.120 |
Why?
|
| Solubility | 1 | 2015 | 178 | 0.120 |
Why?
|
| Insulin | 1 | 1999 | 1155 | 0.120 |
Why?
|
| Atrial Fibrillation | 2 | 2015 | 348 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2017 | 501 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1592 | 0.120 |
Why?
|
| Young Adult | 2 | 2018 | 6218 | 0.120 |
Why?
|
| Risk | 2 | 2005 | 660 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 388 | 0.120 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 1999 | 16 | 0.120 |
Why?
|
| Animals | 6 | 2020 | 27233 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 602 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2013 | 327 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 179 | 0.110 |
Why?
|
| Needles | 1 | 1993 | 36 | 0.110 |
Why?
|
| Hemodilution | 1 | 1993 | 13 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2013 | 122 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2009 | 837 | 0.110 |
Why?
|
| Christianity | 1 | 1993 | 37 | 0.110 |
Why?
|
| Blood Circulation | 1 | 1993 | 30 | 0.110 |
Why?
|
| Ventilators, Mechanical | 1 | 1993 | 37 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 146 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 90 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2016 | 269 | 0.110 |
Why?
|
| Brain Abscess | 1 | 1992 | 8 | 0.110 |
Why?
|
| Catheter Ablation | 1 | 2015 | 251 | 0.100 |
Why?
|
| Craniotomy | 1 | 1992 | 88 | 0.100 |
Why?
|
| Fatal Outcome | 3 | 2015 | 295 | 0.100 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 54 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 102 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 360 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 685 | 0.090 |
Why?
|
| Electroencephalography | 1 | 2015 | 741 | 0.090 |
Why?
|
| Complement Activation | 2 | 2002 | 81 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 70 | 0.090 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2011 | 107 | 0.090 |
Why?
|
| International Normalized Ratio | 2 | 2010 | 39 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 2019 | 0.090 |
Why?
|
| Acidosis, Lactic | 1 | 2009 | 10 | 0.090 |
Why?
|
| Organizational Policy | 1 | 2009 | 55 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2009 | 65 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2011 | 381 | 0.080 |
Why?
|
| Blood Loss, Surgical | 1 | 2009 | 115 | 0.080 |
Why?
|
| United States | 2 | 2018 | 6882 | 0.080 |
Why?
|
| Thoracotomy | 2 | 2007 | 61 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 51 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2011 | 335 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2018 | 1037 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2011 | 389 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2008 | 28 | 0.080 |
Why?
|
| Logistic Models | 1 | 2011 | 1205 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2018 | 3368 | 0.080 |
Why?
|
| Venae Cavae | 1 | 2007 | 14 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 430 | 0.070 |
Why?
|
| Placebos | 2 | 1998 | 214 | 0.070 |
Why?
|
| Chicago | 1 | 2011 | 1411 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2336 | 0.070 |
Why?
|
| Hospitals | 1 | 2009 | 298 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 112 | 0.070 |
Why?
|
| Prothrombin Time | 1 | 2005 | 20 | 0.070 |
Why?
|
| Partial Thromboplastin Time | 1 | 2005 | 18 | 0.070 |
Why?
|
| Adolescent | 1 | 2018 | 9157 | 0.070 |
Why?
|
| Mice | 1 | 2018 | 11710 | 0.060 |
Why?
|
| Popliteal Vein | 1 | 2004 | 4 | 0.060 |
Why?
|
| Subclavian Artery | 1 | 2004 | 43 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2004 | 103 | 0.060 |
Why?
|
| Warfarin | 1 | 2004 | 104 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2593 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 107 | 0.060 |
Why?
|
| Radiography | 1 | 2005 | 807 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2004 | 238 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2015 | 706 | 0.050 |
Why?
|
| Oxygenators | 1 | 2002 | 3 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2004 | 167 | 0.050 |
Why?
|
| Vacuum | 1 | 2021 | 10 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2003 | 329 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2004 | 210 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2001 | 32 | 0.050 |
Why?
|
| Decision Making | 1 | 2007 | 661 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2004 | 229 | 0.050 |
Why?
|
| Drainage | 1 | 2001 | 158 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 1588 | 0.050 |
Why?
|
| Mitral Valve Prolapse | 1 | 2000 | 24 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 460 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2021 | 146 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 1999 | 52 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2000 | 135 | 0.040 |
Why?
|
| S100 Proteins | 1 | 1999 | 51 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2000 | 87 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1999 | 8 | 0.040 |
Why?
|
| Complement C3a | 1 | 1999 | 11 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 143 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 1999 | 102 | 0.040 |
Why?
|
| Hyperthermia, Induced | 1 | 1999 | 73 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 204 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 273 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2000 | 460 | 0.040 |
Why?
|
| Counterpulsation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 1998 | 140 | 0.040 |
Why?
|
| Hypertension | 1 | 2004 | 733 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 1998 | 72 | 0.040 |
Why?
|
| Carotid Stenosis | 1 | 2019 | 115 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 142 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 799 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2019 | 167 | 0.040 |
Why?
|
| Epinephrine | 1 | 1996 | 86 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 241 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2638 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1996 | 170 | 0.030 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2015 | 17 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 699 | 0.030 |
Why?
|
| Pruritus | 1 | 1995 | 29 | 0.030 |
Why?
|
| Urinary Retention | 1 | 1995 | 42 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1997 | 230 | 0.030 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2017 | 188 | 0.030 |
Why?
|
| Gene Expression | 1 | 1999 | 1312 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 1996 | 231 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 1995 | 117 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 254 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 253 | 0.030 |
Why?
|
| Nausea | 1 | 1995 | 176 | 0.030 |
Why?
|
| Vomiting | 1 | 1995 | 193 | 0.030 |
Why?
|
| Respiration | 1 | 1995 | 266 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 609 | 0.030 |
Why?
|
| Vasodilation | 1 | 2013 | 94 | 0.030 |
Why?
|
| Blood Volume | 1 | 1993 | 49 | 0.030 |
Why?
|
| Extracorporeal Circulation | 1 | 1993 | 34 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2013 | 186 | 0.030 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2013 | 120 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 684 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2015 | 567 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 1142 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2013 | 299 | 0.020 |
Why?
|
| Intracranial Aneurysm | 1 | 1993 | 174 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 1992 | 117 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1992 | 174 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2010 | 23 | 0.020 |
Why?
|
| Cystoscopy | 1 | 2010 | 39 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 2010 | 47 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 100 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1945 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 838 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 71 | 0.020 |
Why?
|
| Hemostatics | 1 | 2008 | 57 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3445 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2000 | 18 | 0.010 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2000 | 42 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 167 | 0.010 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 1999 | 3 | 0.010 |
Why?
|
| Receptors, LH | 1 | 1999 | 7 | 0.010 |
Why?
|
| CHO Cells | 1 | 1999 | 187 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 560 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 797 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2000 | 457 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 565 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 884 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1790 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2879 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1999 | 1295 | 0.010 |
Why?
|